Immunotherapy plus chemoradiotherapy (unspecified agents)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immunotherapy plus chemoradiotherapy (unspecified agents), covering 2025-06-03 to 2025-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR） [NA]